Austere Pharma facility at UK, started its commercial production from 2005. The plant is in accordance with the guidelines of various international regulatory bodies like US-FDA, TGA, MHRA, MCC, WHO, ANVISA etc, which is the true testimony of Austere Pharma Pvt Ltd’s commitment towards quality and safety. Such standards helped Austere to attain strong footholds in the global market.
WHO-GMP Certified Unit with state-of-the-art infrastructure
Auster offers multiple production capabilities and high flexibility in all product categories Oral solids, Oral liquids, Sterile preparations (eye and ear) and Nasal preparations. The company has the adaptability to produce volumes from a pilot batch to commercial batches with consistent quality.
Austere Pharma Ltd has adopted a state-of-the-art infrastructure, equipped with modern automation system. The whole facility is in the controlled environment in accordance with cGMP guidelines. This facility also complies with the stringent guidelines stipulated by various international bodies such as WHO GMP, US-FDA, TGA and MHRA.